Log in to save to my catalogue

PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells

PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8666826

PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells

About this item

Full title

PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells

Publisher

England: BMJ Publishing Group Ltd and British Society of Gastroenterology

Journal title

Gut, 2022-01, Vol.71 (1), p.119-128

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd and British Society of Gastroenterology

More information

Scope and Contents

Contents

ObjectiveCancer stem cells are responsible for tumour spreading and relapse. Human epidermal growth factor receptor 2 (HER2) expression is a negative prognostic factor in colorectal cancer (CRC) and a potential target in tumours carrying the gene amplification. Our aim was to define the expression of HER2 in colorectal cancer stem cells (CR-CSCs) a...

Alternative Titles

Full title

PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8666826

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8666826

Other Identifiers

ISSN

0017-5749

E-ISSN

1468-3288

DOI

10.1136/gutjnl-2020-323553

How to access this item